malondialdehyde has been researched along with Pulmonary Arterial Hypertension in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, S; Cui, H; Du, GQ; Li, Y; Shen, W; Sun, P; Wang, C; Xue, JY; Zhao, P | 1 |
| An, N; Feng, W; Feng, Z; Guan, H; Hu, T; Hu, Y; Liu, J; Mao, Y; Mou, J; Zhang, D | 1 |
| Li, Y; Liu, Y; Nie, X; Sun, Z; Wang, Q; Wang, T; Zhu, J | 1 |
3 other study(ies) available for malondialdehyde and Pulmonary Arterial Hypertension
| Article | Year |
|---|---|
Melatonin activates the Mst1-Nrf2 signaling to alleviate cardiac hypertrophy in pulmonary arterial hypertension.
Topics: Animals; Antioxidants; Arginine Vasopressin; Cysteine; Disease Models, Animal; Familial Primary Pulmonary Hypertension; Hepatocyte Growth Factor; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Malondialdehyde; Melatonin; Monocrotaline; NF-E2-Related Factor 2; Proto-Oncogene Proteins; Pulmonary Arterial Hypertension; Rats; RNA, Small Interfering; Ventricular Remodeling | 2022 |
Alginate Oligosaccharide Alleviates Monocrotaline-Induced Pulmonary Hypertension via Anti-Oxidant and Anti-Inflammation Pathways in Rats.
Topics: Alginates; Animals; Anti-Inflammatory Agents; Antioxidants; Disease Models, Animal; Dose-Response Relationship, Drug; Hypertrophy, Right Ventricular; Injections, Intraperitoneal; Male; Malondialdehyde; Monocrotaline; Pulmonary Arterial Hypertension; Random Allocation; Rats; Vascular Remodeling | 2020 |
NDUFA4L2 in smooth muscle promotes vascular remodeling in hypoxic pulmonary arterial hypertension.
Topics: Aldehydes; Animals; Arachidonate 5-Lipoxygenase; Cell Hypoxia; Cell Proliferation; Disease Models, Animal; Electron Transport Complex I; Endothelial Cells; Gene Expression Regulation; Gene Silencing; Humans; Hypoxia; Male; Malondialdehyde; Models, Biological; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Oxidation-Reduction; Oxygen Consumption; p38 Mitogen-Activated Protein Kinases; Pulmonary Arterial Hypertension; Pulmonary Artery; Rats, Wistar; Reactive Oxygen Species; RNA, Messenger; Vascular Remodeling | 2021 |